Pathogenicity and susceptibility profile of nontuberculous mycobacteria from 16 , 578 suspected pulmonary tuberculosis patients
Wei Zhang,Wei Liu,G. Fang,Jun Ma,Chaolin Huang,Dingyu Zhang
2016-01-01
Abstract:Knowledge of local species variation in nontuberculous mycobacteria (NTM), accurate identification of causative species and determination of their susceptibility to antimicrobial agents would help targeted therapy. This hospital-based retrospective study was performed to analyze the species distribution of the NTM isolated from respiratory samples, evaluate their overall degree of pathogenicity, and determine their drug susceptibility. 40,900 respiratory samples (40,041 were from sputum and 859 from broncho-alveolar lavage fluid) and medical records were collected from 16,578 suspected pulmonary tuberculosis (TB) cases at Wuhan Medical Treatment Center (Wuhan, China) from January 1, 2015 to December 31, 2015. Acid-fast bacilli (AFB) culture and PNB/TCH (p-nitrobenzoic acid/thiophene-2-carboxylic acid hydrazide) culture were executed in respiratory samples to isolate mycobacteria and distinguish NTM from Mycobacterium tuberculosis (MTB). PCR amplification and gene sequencing were conducted for bacterial DNA of NTM isolates to identify NTM species. Overall degree of pathogenicity for the NTM isolates was evaluated and susceptibility to antimicrobial agents were tested. During the study period, positive results of mycobacterium culture were obtained in 5,123 samples from 2,056 cases. 395 NTM isolates were revealed in 152 cases among the 2,056. According to the definition or diagnostic criteria, 32 within the 152 had confirmed diagnosis of NTM lung disease. Accordingly, overall degree of pathogenicity of the NTM isolates was 0.211 (32/152). Moreover, the species identified in 301 NTM isolates that were subjected to gene sequencing were M. abscessus (135, 45.0%), M. avium-intracellul are complex (MAIC, 130, 43.1%), M. kansasii (32, 10.6%) and M. gordonae (4, 1.3%). The proportion of NTM isolates susceptible to antimicrobial agents were 100%, 100%, 57.0%, 94.8%, 54.8% and 35.6% for M. abscessus to amikacin, cefoxitin, ciprofloxacin, clarithromycin, imipenem and tobramycins, 90.0% for MAIC to amikacin and clarithromycin, and 96.9%, 53.1%, 96.9%, 93.8% and 71.9% for M. kansasii to amikacin, ciprofloxacin, clarithromycin, ethambutol and rifampin, respectively. In conclusion, results obtained from the present study manifested that overall degree of pathogenicity of the NTM isolates was 0.211 at Wuhan Medical Treatment Center (Wuhan, China) in 2015. There existed a relatively higher proportion of antimicrobial resistance for M. kansasii to ciprofloxacin (46.9%), and that for M. abscessus to ciprofloxacin (43.0%), imipenem (45.2%) and tobramycins (64.4%) respectively, suggesting the indispensability that clinicians should have treatment options according to the species identified and their susceptibility profile.